Co
No verificado

Cosette Pharmaceuticals, Inc.

Sobre qué escribimos

BiotecnologíaFarmacéuticaIndustriaSaludSanidad
10/11/2026
Multimedia
Industria
Biotecnología
Medicina - Varios
Sanidad
Salud
Farmacéutica
Cosette Pharma’s RYANODEX® (dantrolene sodium) for Injectable Suspension, Fully Stocked and Available
1.00
19/05/2026
Biotecnología
Sanidad
Farmacéutica
Salud
Mercado laboral
Cosette Pharmaceuticals Appoints David Bell as Chief Commercial Officer (Brands)
1.00
08/04/2026
Mercado de valores
Industria
Salud
Higiene alimentaria
Sanidad
Farmacéutica
Biotecnología
Cosette Pharmaceuticals Expands Branded Portfolio through Acquisition of SYMPAZAN® and Additional Products from Assertio
1.00
11/12/2025
Mercado de valores
Salud
Farmacéutica
Termination of Proposed Acquisition of Mayne Pharma
1.00

Detalles de contacto

Redes sociales

Seguidores
0
Compatibilidad
0